STOK
Stoke Therapeutics Inc
NASDAQ: STOK · HEALTHCARE · BIOTECHNOLOGY
$32.42
-2.73% today
Updated 2026-04-29
Market cap
$1.92B
P/E ratio
—
P/S ratio
10.40x
EPS (TTM)
$-0.12
Dividend yield
—
52W range
$8 – $40
Volume
0.8M
Stoke Therapeutics Inc (STOK) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $3.00M | $12.40M | $8.78M | $36.55M | $184.42M |
| Revenue growth (YoY) | — | — | — | — | — | +313.5% | -29.2% | +316.3% | +404.5% |
| Cost of revenue | $113000.00 | $214000.00 | $450000.00 | $1.93M | $2.23M | $3.54M | $4.73M | $4.44M | — |
| Gross profit | $-113000.00 | $-214000.00 | $-450000.00 | $-1.93M | $-2.23M | $12.40M | $8.78M | $36.55M | $184.42M |
| Gross margin | — | — | — | — | -74.3% | 100.0% | 100.0% | 100.0% | 100.0% |
| R&D | $3.60M | $8.37M | $23.76M | $32.20M | $54.17M | $77.84M | $82.23M | $89.13M | $137.92M |
| SG&A | $1.96M | $4.41M | $11.91M | $20.85M | $31.90M | $38.92M | $41.32M | $48.79M | $67.09M |
| Operating income | $-5.55M | $-12.78M | $-35.68M | $-53.04M | $-86.06M | $-104.36M | $-114.77M | $-101.37M | $-20.59M |
| Operating margin | — | — | — | — | -2868.8% | -841.2% | -1307.2% | -277.3% | -11.2% |
| EBITDA | $-5.44M | $-12.57M | $-35.23M | $-52.16M | $-85.09M | $-102.81M | $-112.30M | $-99.19M | $-18.82M |
| EBITDA margin | — | — | — | — | -2836.4% | -828.8% | -1279.1% | -271.4% | -10.2% |
| EBIT | $-5.55M | $-12.78M | $-35.68M | $-53.04M | $-86.06M | $-104.36M | $-114.77M | $-101.37M | $-20.59M |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $120000.00 | $3.12M | $9.91M | $12.64M | $13.76M |
| Income tax | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-5.56M | $-12.52M | $-28.52M | $-50.61M | $-84.71M | $-93.11M | $-104.70M | $-88.98M | $-6.88M |
| Net income growth (YoY) | — | -125.3% | -127.8% | -77.4% | -67.4% | -9.9% | -12.4% | +15.0% | +92.3% |
| Profit margin | — | — | — | — | -2823.7% | -750.6% | -1192.5% | -243.4% | -3.7% |